In Treatment of Chronic hepatitis C virus (HCV) infection Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Myhep All Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor.
It is not known whether it is safe to consume alcohol with Myhep All Tablet. Please consult your doctor.
Myhep All Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Myhep All Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Myhep All Tablet may cause side effects which could affect your ability to drive. Myhep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Myhep All Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Myhep All Tablet may be needed. Please consult your doctor. Limited information is available on the use of Myhep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Myhep All Tablet is safe to use in patients with liver disease. No dose adjustment of Myhep All Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
If you miss a dose of Myhep All Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Natco Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aprazer Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Taj Pharma India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)